Similar to IGF2BP1, we provide complementary evidence that MSI1 is not co-purified with AGO2 and that its downregulation or deletion enhances the miRNA-dependent downregulation of the CD44 mRNA in GBM-derived cells. This evidence concerns the gene AGO2 and glioblastoma.